North America Ruminant Vaccines Market Size, Share & Trends Analysis Report By Animal Type (Cattle, and Sheep & Goats), By Vaccines Type, By Route of Administration, By Indication, By Country and Growth Forecast, 2024 - 2031

The North America Ruminant Vaccines Market would witness market growth of 5.9% CAGR during the forecast period (2024-2031).

The US market dominated the North America Ruminant Vaccines Market by Country in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $1,257.3 million by 2031. The Canada market is experiencing a CAGR of 8% during (2024 - 2031). Additionally, The Mexico market would exhibit a CAGR of 7% during (2024 - 2031).



The ruminant vaccines market refers to the segment of the veterinary pharmaceutical industry that focuses on developing, manufacturing, distributing, and selling vaccines specifically designed for ruminant species. Ruminants are a group of mammals with a unique digestive system capable of digesting plant-based diets through rumination. Common ruminant species include cattle (both beef and dairy), sheep, goats, and certain species of deer.

The vaccines are crucial in preventing and controlling a wide range of infectious diseases affecting cattle, sheep, goats, and other ruminant species. These vaccines are utilized in various applications within livestock production systems to safeguard animal health, improve production efficiency, and reduce economic losses. For example, respiratory diseases are a significant concern in ruminant production systems, particularly in intensive or confined housing environments.

With the expansion of the red meat industry in Canada, there is a heightened need for disease prevention and control measures to safeguard the health and productivity of ruminant livestock. The Canadian government states that the country's red meat sector consists of pig, lamb mutton, goat, rabbit, horse, venison, bison, and beef & veal. In 2022, the red meat business had annual shipments of $24.72 billion. There were 1,040,200 sheep and lambs as of 2019. Most of Canada's sheep are produced in Ontario, Quebec, and Alberta (72%). Sheep and lamb farm cash receipts in 2019 totaled $189 million, or 0.3% of overall agricultural cash receipts. Thus, the rising meat industry in the region is driving the market’s growth.

Based on Animal Type, the market is segmented into Cattle, and Sheep & Goats. Based on Vaccines Type, the market is segmented into Modified/ Attenuated Live, Inactivated (Killed), and Others. Based on Route of Administration, the market is segmented into Injectable, and Intranasal. Based on Indication, the market is segmented into Bovine Respiratory Diseases (BRD), Diarrhea/ Scours, FMD, Clostridial Diseases, Leptospirosis, BVD Infection, and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.

List of Key Companies Profiled

• Boehringer Ingelheim International GmbH
• Zoetis, Inc.
• Merck & Co., Inc.
• Bimeda, Inc.
• Elanco Animal Health, Inc.
• Virbac
• Ceva Sante Animale
• CZ Vaccines S.A.U. (Zendal Health S.A.)
• Indian Immunologicals Ltd. (National Dairy Development Board)
• Vaxxinova International BV (EW Group)

Market Report Segmentation

By Animal Type

• Cattle
• Sheep & Goats

By Vaccines Type

• Modified/ Attenuated Live
• Inactivated (Killed)
• Others

By Route of Administration

• Injectable
• Intranasal

By Indication

• Bovine Respiratory Diseases (BRD)
• Diarrhea/ Scours
• FMD
• Clostridial Diseases
• Leptospirosis
• BVD Infection
• Others

By Country

• US
• Canada
• Mexico
• Rest of North America